<DOC>
	<DOCNO>NCT00286104</DOCNO>
	<brief_summary>External ventricular catheter use intracranial pressure monitor temporary cerebrospinal fluid ( CSF ) drainage neurosurgery . The incidence ventriculostomy-related cerebrospinal fluid infection quote 2.2 % 10.4 % recent literature . Previous prospective study investigator ' unit show use dual antibiotic prophylaxis patient external ventricular drain associate decreased incidence CSF infection complicate opportunistic extracranial infection . The current practice cover prophylactic dual antibiotic unless guide microbiology result patient external ventricular drain . In recent year , cerebrospinal fluid shunt catheter impregnate antimicrobial agent available . Experimental study show provide protection staphylococcal aureus coagulase-negative staphylococci strain 42 day 56 day . Theoretically , provide antibiotic prophylaxis locally without associate complication systemic antibiotic . It hypothesize use antibiotic-impregnated catheter instead systemic antibiotic prophylaxis increase rate cerebrospinal fluid infection , decrease rate opportunistic/nosocomial infection improve overall outcome patient ; would convert reduction treatment cost patient .</brief_summary>
	<brief_title>Impact Ventricular Catheter Used With Antimicrobial Agents Patients With Ventricular Catheter</brief_title>
	<detailed_description>Objective : 1 . To assess cranial extracranial infection rate systemic antibiotic prophylaxis versus antibiotics-impregnated catheter . 2 . To assess patient ' outcome carry cost analysis systemic antibiotic prophylaxis versus antibiotics-impregnated catheter . Design : Prospective randomized control trial Hypothesis : The use antibiotics-impregnated catheter instead systemic antibiotic prophylaxis increase rate cerebrospinal fluid infection , decrease rate opportunistic/nosocomial infection improve overall outcome patient ; would convert reduction treatment cost patient . Method : After ventricular catheter insertion , patient randomize one two group : 1 . Periprocedural antibiotic : Only ie Unasyn Rocephin insertion antibiotics-impregnated ventricular catheter . 2 . Periprocedural antibiotic prophylactic dual antibiotic ie Unasyn Rocephin insertion ventricular catheter without impregnation antibiotic . Primary outcome variable : Cerebrospinal fluid infection extracranial infection . Sample size : We aim recruit total 180 patient 90 patient arm expect complete patient recruitment 2-3 year . The calculation base detect difference nosocomial infection rate 20 % 40 % , 5 % level significance 80 % power . Projected result significance : The project good chance first clinical study outcome cost impact antibiotic-impregnated ventricular catheter .</detailed_description>
	<mesh_term>Hydrocephalus</mesh_term>
	<mesh_term>Intracranial Hypertension</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>1 . Patients external ventricular drain insert 2 . Patients external ventricular drain insitu plan least 5 day 1 . Known CSF infection include meningitis 2 . Known sepsis 3 . Uncorrected coagulopathy 4 . No consent available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Ventriculitis</keyword>
	<keyword>External ventricular catheter</keyword>
	<keyword>Antibiotic-impregnated</keyword>
</DOC>